img

Global Alpha L-Iduronidase Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Alpha L-Iduronidase Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).
Alpha L-Iduronidase report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Alpha L-Iduronidase market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Dermatology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Alpha L-Iduronidase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Alpha L-Iduronidase key manufacturers include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc and Ossianix Inc, etc. ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc are top 3 players and held % sales share in total in 2022.
Alpha L-Iduronidase can be divided into IDUA and EC 3.2.1.76, etc. IDUA is the mainstream product in the market, accounting for % sales share globally in 2022.
Alpha L-Iduronidase is widely used in various fields, such as Oncology, Dermatology, Immunology and Musculoskeletal Disorders, etc. Oncology provides greatest supports to the Alpha L-Iduronidase industry development. In 2022, global % sales of Alpha L-Iduronidase went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alpha L-Iduronidase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Segment by Type
IDUA
EC 3.2.1.76

Segment by Application


Oncology
Dermatology
Immunology
Musculoskeletal Disorders

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alpha L-Iduronidase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Alpha L-Iduronidase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Alpha L-Iduronidase industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Alpha L-Iduronidase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Alpha L-Iduronidase introduction, etc. Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Alpha L-Iduronidase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Alpha L-Iduronidase Market Overview
1.1 Alpha L-Iduronidase Product Overview
1.2 Alpha L-Iduronidase Market Segment by Type
1.2.1 IDUA
1.2.2 EC 3.2.1.76
1.3 Global Alpha L-Iduronidase Market Size by Type
1.3.1 Global Alpha L-Iduronidase Market Size Overview by Type (2024-2034)
1.3.2 Global Alpha L-Iduronidase Historic Market Size Review by Type (2024-2024)
1.3.3 Global Alpha L-Iduronidase Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Alpha L-Iduronidase Sales Breakdown by Type (2024-2024)
1.4.2 Europe Alpha L-Iduronidase Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Alpha L-Iduronidase Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Alpha L-Iduronidase Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Alpha L-Iduronidase Sales Breakdown by Type (2024-2024)
2 Global Alpha L-Iduronidase Market Competition by Company
2.1 Global Top Players by Alpha L-Iduronidase Sales (2024-2024)
2.2 Global Top Players by Alpha L-Iduronidase Revenue (2024-2024)
2.3 Global Top Players by Alpha L-Iduronidase Price (2024-2024)
2.4 Global Top Manufacturers Alpha L-Iduronidase Manufacturing Base Distribution, Sales Area, Product Type
2.5 Alpha L-Iduronidase Market Competitive Situation and Trends
2.5.1 Alpha L-Iduronidase Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Alpha L-Iduronidase Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alpha L-Iduronidase as of 2022)
2.7 Date of Key Manufacturers Enter into Alpha L-Iduronidase Market
2.8 Key Manufacturers Alpha L-Iduronidase Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Alpha L-Iduronidase Status and Outlook by Region
3.1 Global Alpha L-Iduronidase Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Alpha L-Iduronidase Historic Market Size by Region
3.2.1 Global Alpha L-Iduronidase Sales in Volume by Region (2024-2024)
3.2.2 Global Alpha L-Iduronidase Sales in Value by Region (2024-2024)
3.2.3 Global Alpha L-Iduronidase Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Alpha L-Iduronidase Forecasted Market Size by Region
3.3.1 Global Alpha L-Iduronidase Sales in Volume by Region (2024-2034)
3.3.2 Global Alpha L-Iduronidase Sales in Value by Region (2024-2034)
3.3.3 Global Alpha L-Iduronidase Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Alpha L-Iduronidase by Application
4.1 Alpha L-Iduronidase Market Segment by Application
4.1.1 Oncology
4.1.2 Dermatology
4.1.3 Immunology
4.1.4 Musculoskeletal Disorders
4.2 Global Alpha L-Iduronidase Market Size by Application
4.2.1 Global Alpha L-Iduronidase Market Size Overview by Application (2024-2034)
4.2.2 Global Alpha L-Iduronidase Historic Market Size Review by Application (2024-2024)
4.2.3 Global Alpha L-Iduronidase Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Alpha L-Iduronidase Sales Breakdown by Application (2024-2024)
4.3.2 Europe Alpha L-Iduronidase Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Alpha L-Iduronidase Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Alpha L-Iduronidase Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Alpha L-Iduronidase Sales Breakdown by Application (2024-2024)
5 North America Alpha L-Iduronidase by Country
5.1 North America Alpha L-Iduronidase Historic Market Size by Country
5.1.1 North America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Alpha L-Iduronidase Sales in Volume by Country (2024-2024)
5.1.3 North America Alpha L-Iduronidase Sales in Value by Country (2024-2024)
5.2 North America Alpha L-Iduronidase Forecasted Market Size by Country
5.2.1 North America Alpha L-Iduronidase Sales in Volume by Country (2024-2034)
5.2.2 North America Alpha L-Iduronidase Sales in Value by Country (2024-2034)
6 Europe Alpha L-Iduronidase by Country
6.1 Europe Alpha L-Iduronidase Historic Market Size by Country
6.1.1 Europe Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Alpha L-Iduronidase Sales in Volume by Country (2024-2024)
6.1.3 Europe Alpha L-Iduronidase Sales in Value by Country (2024-2024)
6.2 Europe Alpha L-Iduronidase Forecasted Market Size by Country
6.2.1 Europe Alpha L-Iduronidase Sales in Volume by Country (2024-2034)
6.2.2 Europe Alpha L-Iduronidase Sales in Value by Country (2024-2034)
7 Asia-Pacific Alpha L-Iduronidase by Region
7.1 Asia-Pacific Alpha L-Iduronidase Historic Market Size by Region
7.1.1 Asia-Pacific Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Alpha L-Iduronidase Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Alpha L-Iduronidase Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Alpha L-Iduronidase Forecasted Market Size by Region
7.2.1 Asia-Pacific Alpha L-Iduronidase Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Alpha L-Iduronidase Sales in Value by Region (2024-2034)
8 Latin America Alpha L-Iduronidase by Country
8.1 Latin America Alpha L-Iduronidase Historic Market Size by Country
8.1.1 Latin America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Alpha L-Iduronidase Sales in Volume by Country (2024-2024)
8.1.3 Latin America Alpha L-Iduronidase Sales in Value by Country (2024-2024)
8.2 Latin America Alpha L-Iduronidase Forecasted Market Size by Country
8.2.1 Latin America Alpha L-Iduronidase Sales in Volume by Country (2024-2034)
8.2.2 Latin America Alpha L-Iduronidase Sales in Value by Country (2024-2034)
9 Middle East and Africa Alpha L-Iduronidase by Country
9.1 Middle East and Africa Alpha L-Iduronidase Historic Market Size by Country
9.1.1 Middle East and Africa Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Alpha L-Iduronidase Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Alpha L-Iduronidase Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Alpha L-Iduronidase Forecasted Market Size by Country
9.2.1 Middle East and Africa Alpha L-Iduronidase Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Alpha L-Iduronidase Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ArmaGen Inc
10.1.1 ArmaGen Inc Company Information
10.1.2 ArmaGen Inc Introduction and Business Overview
10.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.1.4 ArmaGen Inc Alpha L-Iduronidase Products Offered
10.1.5 ArmaGen Inc Recent Development
10.2 BioStrategies LC
10.2.1 BioStrategies LC Company Information
10.2.2 BioStrategies LC Introduction and Business Overview
10.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.2.4 BioStrategies LC Alpha L-Iduronidase Products Offered
10.2.5 BioStrategies LC Recent Development
10.3 Denali Therapeutics Inc
10.3.1 Denali Therapeutics Inc Company Information
10.3.2 Denali Therapeutics Inc Introduction and Business Overview
10.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Products Offered
10.3.5 Denali Therapeutics Inc Recent Development
10.4 EdiGene Inc
10.4.1 EdiGene Inc Company Information
10.4.2 EdiGene Inc Introduction and Business Overview
10.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.4.4 EdiGene Inc Alpha L-Iduronidase Products Offered
10.4.5 EdiGene Inc Recent Development
10.5 Gain Therapeutics Inc
10.5.1 Gain Therapeutics Inc Company Information
10.5.2 Gain Therapeutics Inc Introduction and Business Overview
10.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Products Offered
10.5.5 Gain Therapeutics Inc Recent Development
10.6 Immusoft Corp
10.6.1 Immusoft Corp Company Information
10.6.2 Immusoft Corp Introduction and Business Overview
10.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Immusoft Corp Alpha L-Iduronidase Products Offered
10.6.5 Immusoft Corp Recent Development
10.7 JCR Pharmaceuticals Co Ltd
10.7.1 JCR Pharmaceuticals Co Ltd Company Information
10.7.2 JCR Pharmaceuticals Co Ltd Introduction and Business Overview
10.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Products Offered
10.7.5 JCR Pharmaceuticals Co Ltd Recent Development
10.8 Orchard Therapeutics Plc
10.8.1 Orchard Therapeutics Plc Company Information
10.8.2 Orchard Therapeutics Plc Introduction and Business Overview
10.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Products Offered
10.8.5 Orchard Therapeutics Plc Recent Development
10.9 Ossianix Inc
10.9.1 Ossianix Inc Company Information
10.9.2 Ossianix Inc Introduction and Business Overview
10.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Ossianix Inc Alpha L-Iduronidase Products Offered
10.9.5 Ossianix Inc Recent Development
10.10 Rain Bio Inc
10.10.1 Rain Bio Inc Company Information
10.10.2 Rain Bio Inc Introduction and Business Overview
10.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Rain Bio Inc Alpha L-Iduronidase Products Offered
10.10.5 Rain Bio Inc Recent Development
10.11 RegenxBio Inc
10.11.1 RegenxBio Inc Company Information
10.11.2 RegenxBio Inc Introduction and Business Overview
10.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.11.4 RegenxBio Inc Alpha L-Iduronidase Products Offered
10.11.5 RegenxBio Inc Recent Development
10.12 Tega Therapeutics Inc
10.12.1 Tega Therapeutics Inc Company Information
10.12.2 Tega Therapeutics Inc Introduction and Business Overview
10.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Products Offered
10.12.5 Tega Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Alpha L-Iduronidase Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Alpha L-Iduronidase Industrial Chain Analysis
11.4 Alpha L-Iduronidase Market Dynamics
11.4.1 Alpha L-Iduronidase Industry Trends
11.4.2 Alpha L-Iduronidase Market Drivers
11.4.3 Alpha L-Iduronidase Market Challenges
11.4.4 Alpha L-Iduronidase Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Alpha L-Iduronidase Distributors
12.3 Alpha L-Iduronidase Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of IDUA
Table 2. Major Company of EC 3.2.1.76
Table 3. Global Alpha L-Iduronidase Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Alpha L-Iduronidase Sales by Type (2024-2024) & (K Units)
Table 5. Global Alpha L-Iduronidase Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Alpha L-Iduronidase Sales by Type (2024-2024) & (US& Million)
Table 7. Global Alpha L-Iduronidase Market Share in Value by Type (2024-2024)
Table 8. Global Alpha L-Iduronidase Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Alpha L-Iduronidase Sales by Type (2024-2034) & (K Units)
Table 10. Global Alpha L-Iduronidase Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Alpha L-Iduronidase Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Alpha L-Iduronidase Sales Market Share in Value by Type (2024-2034)
Table 13. Global Alpha L-Iduronidase Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Alpha L-Iduronidase Sales by Type (2024-2024) & (K Units)
Table 15. North America Alpha L-Iduronidase Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Alpha L-Iduronidase Sales (K Units) by Type (2024-2024)
Table 17. Europe Alpha L-Iduronidase Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Alpha L-Iduronidase Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Alpha L-Iduronidase Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Alpha L-Iduronidase Sales (K Units) by Type (2024-2024)
Table 21. Latin America Alpha L-Iduronidase Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Alpha L-Iduronidase Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Alpha L-Iduronidase Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Alpha L-Iduronidase Sales by Company (2024-2024) & (K Units)
Table 25. Global Alpha L-Iduronidase Sales Share by Company (2024-2024)
Table 26. Global Alpha L-Iduronidase Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Alpha L-Iduronidase Revenue Share by Company (2024-2024)
Table 28. Global Market Alpha L-Iduronidase Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Alpha L-Iduronidase Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Alpha L-Iduronidase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alpha L-Iduronidase as of 2022)
Table 32. Date of Key Manufacturers Enter into Alpha L-Iduronidase Market
Table 33. Key Manufacturers Alpha L-Iduronidase Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Alpha L-Iduronidase Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Alpha L-Iduronidase Sales by Region (2024-2024) & (K Units)
Table 37. Global Alpha L-Iduronidase Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Alpha L-Iduronidase Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Alpha L-Iduronidase Sales Market Share in Value by Region (2024-2024)
Table 40. Global Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Alpha L-Iduronidase Sales by Region (2024-2034) & (K Units)
Table 42. Global Alpha L-Iduronidase Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Alpha L-Iduronidase Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Alpha L-Iduronidase Sales Market Share in Value by Region (2024-2034)
Table 45. Global Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Alpha L-Iduronidase Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Alpha L-Iduronidase Sales by Application (2024-2024) & (K Units)
Table 48. Global Alpha L-Iduronidase Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Alpha L-Iduronidase Sales Market Share in Value by Application (2024-2024)
Table 51. Global Alpha L-Iduronidase Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Alpha L-Iduronidase Sales by Application (2024-2034) & (K Units)
Table 53. Global Alpha L-Iduronidase Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Alpha L-Iduronidase Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Alpha L-Iduronidase Sales Market Share in Value by Application (2024-2034)
Table 56. Global Alpha L-Iduronidase Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Alpha L-Iduronidase Sales by Application (2024-2024) (K Units)
Table 58. North America Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Alpha L-Iduronidase Sales by Application (2024-2024) (K Units)
Table 60. Europe Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Alpha L-Iduronidase Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Alpha L-Iduronidase Sales by Application (2024-2024) (K Units)
Table 64. Latin America Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Alpha L-Iduronidase Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Alpha L-Iduronidase Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Alpha L-Iduronidase Sales by Country (2024-2024) & (K Units)
Table 68. North America Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Alpha L-Iduronidase Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2024)
Table 71. North America Alpha L-Iduronidase Sales by Country (2024-2034) & (K Units)
Table 72. North America Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Alpha L-Iduronidase Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Alpha L-Iduronidase Sales by Country (2024-2024) & (K Units)
Table 76. Europe Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Alpha L-Iduronidase Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Alpha L-Iduronidase Sales by Country (2024-2034) & (K Units)
Table 80. Europe Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Alpha L-Iduronidase Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Alpha L-Iduronidase Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Alpha L-Iduronidase Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Alpha L-Iduronidase Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Alpha L-Iduronidase Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Alpha L-Iduronidase Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Alpha L-Iduronidase Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Alpha L-Iduronidase Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Alpha L-Iduronidase Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Alpha L-Iduronidase Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Alpha L-Iduronidase Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Alpha L-Iduronidase Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Alpha L-Iduronidase Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Country (2024-2034)
Table 107. ArmaGen Inc Company Information
Table 108. ArmaGen Inc Introduction and Business Overview
Table 109. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. ArmaGen Inc Alpha L-Iduronidase Product
Table 111. ArmaGen Inc Recent Development
Table 112. BioStrategies LC Company Information
Table 113. BioStrategies LC Introduction and Business Overview
Table 114. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. BioStrategies LC Alpha L-Iduronidase Product
Table 116. BioStrategies LC Recent Development
Table 117. Denali Therapeutics Inc Company Information
Table 118. Denali Therapeutics Inc Introduction and Business Overview
Table 119. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Denali Therapeutics Inc Alpha L-Iduronidase Product
Table 121. Denali Therapeutics Inc Recent Development
Table 122. EdiGene Inc Company Information
Table 123. EdiGene Inc Introduction and Business Overview
Table 124. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. EdiGene Inc Alpha L-Iduronidase Product
Table 126. EdiGene Inc Recent Development
Table 127. Gain Therapeutics Inc Company Information
Table 128. Gain Therapeutics Inc Introduction and Business Overview
Table 129. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Gain Therapeutics Inc Alpha L-Iduronidase Product
Table 131. Gain Therapeutics Inc Recent Development
Table 132. Immusoft Corp Company Information
Table 133. Immusoft Corp Introduction and Business Overview
Table 134. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Immusoft Corp Alpha L-Iduronidase Product
Table 136. Immusoft Corp Recent Development
Table 137. JCR Pharmaceuticals Co Ltd Company Information
Table 138. JCR Pharmaceuticals Co Ltd Introduction and Business Overview
Table 139. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product
Table 141. JCR Pharmaceuticals Co Ltd Recent Development
Table 142. Orchard Therapeutics Plc Company Information
Table 143. Orchard Therapeutics Plc Introduction and Business Overview
Table 144. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Orchard Therapeutics Plc Alpha L-Iduronidase Product
Table 146. Orchard Therapeutics Plc Recent Development
Table 147. Ossianix Inc Company Information
Table 148. Ossianix Inc Introduction and Business Overview
Table 149. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Ossianix Inc Alpha L-Iduronidase Product
Table 151. Ossianix Inc Recent Development
Table 152. Rain Bio Inc Company Information
Table 153. Rain Bio Inc Introduction and Business Overview
Table 154. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Rain Bio Inc Alpha L-Iduronidase Product
Table 156. Rain Bio Inc Recent Development
Table 157. RegenxBio Inc Company Information
Table 158. RegenxBio Inc Introduction and Business Overview
Table 159. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. RegenxBio Inc Alpha L-Iduronidase Product
Table 161. RegenxBio Inc Recent Development
Table 162. Tega Therapeutics Inc Company Information
Table 163. Tega Therapeutics Inc Introduction and Business Overview
Table 164. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Tega Therapeutics Inc Alpha L-Iduronidase Product
Table 166. Tega Therapeutics Inc Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Alpha L-Iduronidase Market Trends
Table 170. Alpha L-Iduronidase Market Drivers
Table 171. Alpha L-Iduronidase Market Challenges
Table 172. Alpha L-Iduronidase Market Restraints
Table 173. Alpha L-Iduronidase Distributors List
Table 174. Alpha L-Iduronidase Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha L-Iduronidase Product Picture
Figure 2. Global Alpha L-Iduronidase Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Alpha L-Iduronidase Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Alpha L-Iduronidase Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of IDUA
Figure 6. Global IDUA Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of EC 3.2.1.76
Figure 8. Global EC 3.2.1.76 Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Alpha L-Iduronidase Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Alpha L-Iduronidase Sales Market Share by Type in 2022 & 2034
Figure 11. North America Alpha L-Iduronidase Sales Market Share in Volume by Type in 2022
Figure 12. North America Alpha L-Iduronidase Sales Market Share in Value by Type in 2022
Figure 13. Europe Alpha L-Iduronidase Sales Market Share in Volume by Type in 2022
Figure 14. Europe Alpha L-Iduronidase Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Type in 2022
Figure 17. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Alpha L-Iduronidase Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Alpha L-Iduronidase Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Alpha L-Iduronidase Revenue in 2022
Figure 23. Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Oncology
Figure 25. Global Oncology Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Dermatology
Figure 27. Global Dermatology Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Immunology
Figure 29. Global Immunology Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Musculoskeletal Disorders
Figure 31. Global Musculoskeletal Disorders Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Alpha L-Iduronidase Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Alpha L-Iduronidase Sales Market Share by Application in 2022 & 2034
Figure 34. North America Alpha L-Iduronidase Sales Market Share in Volume by Application in 2022
Figure 35. North America Alpha L-Iduronidase Sales Market Share in Value by Application in 2022
Figure 36. Europe Alpha L-Iduronidase Sales Market Share in Volume by Application in 2022
Figure 37. Europe Alpha L-Iduronidase Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Application in 2022
Figure 40. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Alpha L-Iduronidase Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Alpha L-Iduronidase Manufacturing Cost Structure
Figure 45. Alpha L-Iduronidase Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed